Moleculin Biotech
MBRX
MBRX
22 hedge funds and large institutions have $2.05M invested in Moleculin Biotech in 2018 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
11% less capital invested
Capital invested by funds: $2.3M → $2.05M (-$243K)
Holders
22
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$18K | |
| 2 | +$8.79K | |
| 3 | +$6K | |
| 4 |
AWM
Avondale Wealth Management
West Lake Hills,
Texas
|
+$4K |
| 5 |
BlackRock
New York
|
+$3.3K |
Top Sellers
| 1 | -$24K | |
| 2 | -$13K | |
| 3 | -$8.94K | |
| 4 |
Commonwealth Equity Services
Waltham,
Massachusetts
|
-$1.56K |
| 5 |
Morgan Stanley
New York
|
-$145 |